GlassScriptPhysician profile
Sara Montanez
NPI 1942439047
$4,842.73
in general payments reported to CMS, 2019-2025
30 companies · $502 in 2025
The $502 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $697 · 2022: $1,059 · 2023: $1,634 · 2024: $951 · 2025: $502.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,067 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,066.67 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $1,277.73 | 2021-2024 | Flexitouch Plus, Entre Plus |
| Janssen Pharmaceuticals, INC | $500.95 | 2021-2024 | Xarelto |
| Shockwave Medical, INC | $389.27 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| W. L. Gore & Associates, INC. | $337.93 | 2021-2024 | Gore Tag Thoracic Branch Endoprosthesis, Gore Viabahn Vbx Balloon Expandable Endo |
| Endologix LLC | $306.46 | 2021-2024 | Ovation Ix Iliac Stent Graft, Torus Stent Graft System, Endocross Device |
| Silk Road Medical, INC. | $277.52 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Aroa Biosurgery Incorporated | $255.01 | 2022-2024 | |
| Lemaitre Vascular, INC. | $182.72 | 2023-2025 | Artegraft Vascular Graft, Hydro Lemaitre Valvulotome, Xenosure Biologic Patch |
| Abbott Laboratories | $144.73 | 2023-2025 | Jeti All In One Non-Sterile Kit, Diamondback Peripheral, Esprit |
| Medtronic, INC. | $124.34 | 2023-2024 | Endurant Iis, Hawkone, Venaseal |
| Boston Scientific Corporation | $116.40 | 2022-2025 | Varithena Administration Pack |
| Ossur Americas, INC. | $101.63 | 2024-2025 | |
| Smith+Nephew, INC. | $100.40 | 2022-2025 | Grafix Pl, Versajet |
| Kerecis Limited | $86.89 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Angiodynamics, INC. | $76.26 | 2022-2024 | Auryon Laser System 100-120 Vac, Venacure 1470 Pro |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $72.18 | 2021-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Bard Peripheral Vascular, INC. | $70.61 | 2022 | |
| Inari Medical, INC. | $67.26 | 2024-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Mimedx Group, INC. | $67.15 | 2025 | |
| Convatec INC. | $51.95 | 2023-2024 | |
| Medline Industries LP | $45.50 | 2022 | |
| Globus Medical, INC. | $35.00 | 2023 | Alif Instruments (Universal) |
| Polynovo North America LLC | $26.87 | 2023 | |
| Innovation Technologies INC | $23.04 | 2024 | Irrisept |
| Biosense Webster, INC. | $19.58 | 2023 | Carto 3 |
| Solventum Corporation | $19.41 | 2025 | Promogran Prisma, Activ.A.C. |
| Bioventus LLC | $19.19 | 2021 | |
| Pfizer INC. | $16.98 | 2022 | |
| Becton, Dickinson and Company | $15.73 | 2024 | Covera |
| Baudax Bio INC. | $14.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Montanez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.